AstraZeneca Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
22 Nov 23 | Buy€233,122 | Michel Demare | Individual | 2,000 | €116.61 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 729,365 | 0.047% |
Public Companies | 739,483 | 0.0477% |
Private Companies | 2,325,764 | 0.15% |
State or Government | 2,731,990 | 0.176% |
General Public | 186,600,069 | 12% |
Institutions | 1,357,108,354 | 87.5% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
155,435,297 | €22.2b | 17.6% | 1.23% | |||
138,230,192 | €19.8b | 2.52% | 0.37% | |||
98,381,345 | €14.1b | 26.1% | 2.36% | |||
71,266,655 | €10.2b | 1.69% | 0.18% | |||
51,642,543 | €7.4b | -3.66% | 0.74% | |||
51,587,810 | €7.4b | 0% | 11.37% | |||
35,427,824 | €5.1b | -0.3% | 0.47% | |||
30,265,911 | €4.3b | -5.18% | 0.3% | |||
27,615,498 | €3.9b | 3.48% | 0.18% | |||
26,525,290 | €3.8b | -0.14% | 0.81% | |||
21,472,587 | €3.1b | -0.1% | 2.41% | |||
18,738,422 | €2.7b | -4.64% | 0.37% | |||
16,721,503 | €2.4b | -0.99% | 0.54% | |||
16,646,778 | €2.4b | 0.33% | 1.16% | |||
15,792,299 | €2.3b | -12.5% | 2.16% | |||
12,400,771 | €1.8b | -1.78% | 0.23% | |||
12,305,976 | €1.8b | 0.17% | 2.64% | |||
11,152,442 | €1.6b | -2.06% | 2.14% | |||
11,084,042 | €1.6b | -18.6% | 1.13% | |||
10,816,529 | €1.5b | -0.24% | 1.25% | |||
10,665,114 | €1.5b | 0.09% | 0.27% | |||
10,442,187 | €1.5b | 22.9% | 2.52% | |||
10,437,760 | €1.5b | 25.3% | 0.44% | |||
9,689,412 | €1.4b | -3.61% | 0.64% | |||
9,320,638 | €1.3b | -11.6% | 0.34% |